Published in Molecular Cancer · View the paper (DOI)
A study led by Olaf Merkel and colleagues identified thyroid hormone receptor TRβ as a key driver of prostate cancer growth, with blocking the receptor inhibiting tumour development. The findings offer new perspectives for treating castration-resistant prostate cancer and provide a potential target for new drugs.
Coverage from 2 institutions